Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sustained Virologic Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00743795
What this trial is testing

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Who this might be right for
HCV Infection
Gilead Sciences 252
Large-scale testing (Phase 3)Ended earlyNCT02465203
What this trial is testing

3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study

Who this might be right for
Hepatitis C, Chronic
Novartis Pharmaceuticals 105
Not applicableEnded earlyNCT02292706
What this trial is testing

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 1,609
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Not applicableUnknownNCT04732832
What this trial is testing

HCV Reinfection in HD Patients Achieving SVR

Who this might be right for
Hepatitis C Virus InfectionHepatitis C Virus Infection, Response to Therapy ofHemodialysis Complication
National Taiwan University Hospital 350
Not applicableStudy completedNCT02817594
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin and Patient Support Program in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 51
Not applicableUnknownNCT03591783
What this trial is testing

Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease

Who this might be right for
Hepatitis c
Assiut University 140
Post-approval studies (Phase 4)Study completedNCT00993122
What this trial is testing

Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) Recipients

Who this might be right for
Hepatitis C
University of Roma La Sapienza 100
Not applicableStudy completedNCT03453346
What this trial is testing

Safety and Efficacy of Generic Sofosbuvir and Ribavirin for Treatment-naive Genotype 2 Chronic Hepatitis C

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus Infection, Response to Therapy of
Kawin Technology Share-holding Co., Ltd. 136
Post-approval studies (Phase 4)Study completedNCT01447420
What this trial is testing

Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 129
Large-scale testing (Phase 3)UnknownNCT03236610
What this trial is testing

Tenofovir Monotherapy in Patients With Chronic Hepatitis B Patients Who Had Achieved Complete Viral Suppression on Entecavir Plus Tenofovir

Who this might be right for
Proportion of Patients With a Sustained Virological Response (Serum HBV DNA <20 IU/mL) at Week 48
Uijeongbu St. Mary Hospital 112
Large-scale testing (Phase 3)Study completedNCT02753699
What this trial is testing

Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

Who this might be right for
Hepatitis C
Debiopharm International SA 723
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Post-approval studies (Phase 4)Active Not RecruitingNCT03520660
What this trial is testing

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Who this might be right for
Diabetes MellitusHepatitis C, ChronicCardiovascular Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 121
Large-scale testing (Phase 3)Ended earlyNCT02478229
What this trial is testing

Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

Who this might be right for
Hepatitis C Viral Infection
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Study completedNCT04449029
What this trial is testing

GSK3228836 in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
GlaxoSmithKline 457
Not applicableStudy completedNCT03659058
What this trial is testing

Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR

Who this might be right for
Fibrosis, Liver
Zagazig University 400
Large-scale testing (Phase 3)Study completedNCT02441283
What this trial is testing

Assess Resistance and Durability of Response to ABT-493 and/or ABT-530

Who this might be right for
Hepatitis C
AbbVie 384
Not applicableUnknownNCT04724785
What this trial is testing

Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients

Who this might be right for
Sustained Virologic ResponseHepatitis B, Chronic
The Second Affiliated Hospital of Chongqing Medical University 10,000
Testing effectiveness (Phase 2)Study completedNCT01356160
What this trial is testing

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 351
Next Page